What diagnostic test should be requested for a patient suspected of having Clostridium difficile infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Testing for Clostridium difficile Infection

Primary Recommendation

Request a multi-step diagnostic algorithm rather than a single test: either GDH screening followed by toxin A/B EIA confirmation, or NAAT followed by toxin EIA confirmation, performed only on unformed stool specimens from patients with ≥3 loose stools in 24 hours. 1, 2

When to Test

  • Only test unformed (liquid/loose) stool specimens from symptomatic patients with ≥3 unformed stools in 24 hours with no obvious alternative explanation 1, 3
  • Testing formed stool results in false positives and unnecessary antibiotic therapy 1, 3
  • Clinical context supporting testing includes: recent antibiotic exposure, hospitalization, fever, abdominal pain, and leukocytosis 1, 3
  • Do not exclude testing based on lack of traditional risk factors - community-acquired CDI occurs in 25-26% of cases without healthcare exposure or recent antibiotics 3

Recommended Testing Algorithms

Two-Step Approach (Preferred)

The most recent guidelines strongly recommend multi-step algorithms over single tests to balance sensitivity and specificity: 2, 3

  1. Option 1: GDH screening → Toxin A/B EIA confirmation

    • GDH is highly sensitive but cannot differentiate toxigenic from non-toxigenic strains 1
    • Positive GDH results require toxin confirmation 1
    • This approach has 94% sensitivity, 99% specificity, 94% PPV, and 99% NPV 4
  2. Option 2: NAAT screening → Toxin EIA confirmation

    • NAAT alone has excellent sensitivity (~95%) but may detect asymptomatic colonization 1, 5
    • Without pre-agreed institutional criteria for stool submission, toxin testing should arbitrate positive NAAT results 2
    • This prevents overdiagnosis and unnecessary treatment 5
  3. Option 3: GDH → Toxin EIA → NAAT for discordant results

    • Three-step algorithm for maximum accuracy 2

Single Test Approaches (Not Recommended as Sole Method)

  • Toxin A/B EIA alone is NOT recommended due to low sensitivity (32-98%, often 39-60%) resulting in significant false negatives 1, 4
  • NAAT alone should only be used in patients with high clinical suspicion for CDI or when institutional pre-agreed criteria for testing are established 1
  • The widespread use of NAAT as sole diagnostic method has led to overdiagnosis by identifying colonized patients rather than true infection 5

Special Circumstances

Patients with Ileus Unable to Produce Stool

  • Request PCR testing of perirectal swabs as an acceptable alternative 1, 2
  • Perirectal swabs demonstrate 95.7% sensitivity, 100% specificity, 100% PPV, and 99.1% NPV compared to stool testing 1, 2
  • Use the same multi-step algorithms recommended for stool specimens when testing perirectal swabs 2

Tests to Avoid or Use Selectively

  • Cell culture cytotoxicity assay (CCA): Reference standard but time-consuming (24-48 hours), requires specialized facilities, not practical for routine use 1
  • Toxigenic culture: Slow turnaround time, may detect colonization (7% of asymptomatic hospitalized patients), reserved for epidemiological typing and strain characterization 1
  • Repeat testing after initial negative: Only useful in selected cases with ongoing high clinical suspicion during epidemic situations 1

Critical Pitfalls to Avoid

  • Never test formed stool - this generates false positives from colonization 1, 3
  • Do not use toxin EIA as the sole test - sensitivity is inadequate (39-60%) and will miss significant cases 1, 4
  • Avoid NAAT alone without confirmatory testing unless institutional criteria ensure appropriate patient selection - this leads to overdiagnosis, unnecessary treatment, and antimicrobial resistance 2, 5
  • Do not test asymptomatic patients or test of cure - up to 7% of hospitalized patients are colonized without disease 1

Interpretation Considerations

  • Positive predictive value of all tests depends heavily on disease prevalence - at 5% prevalence, PPV ranges from 0.28-0.77, but improves to 0.71-1.00 at 50% prevalence 1
  • Clinical correlation is essential: interpret results in context of diarrhea severity, fever, abdominal pain, leukocytosis, creatinine, and serum lactate 1, 3
  • NAAT positivity may represent colonization rather than active infection, which is why toxin confirmation improves clinical specificity 3, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

C. difficile Diagnostic Testing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosis and Management of C. difficile Infection in Primary Care

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the frequency of spontaneous resolution in mild Clostridium difficile colitis?
What is the recommended antibiotic regimen for an adult patient with suspected or confirmed Clostridium difficile (C. difficile) infection, particularly those with severe symptoms or a history of recent antibiotic use, hospitalization, or other risk factors?
What is the best treatment for a patient with a positive Clostridium difficile PCR test after receiving Tazocin (piperacillin/tazobactam) for pneumonia?
What area of the intestine is most commonly affected by Clostridium difficile?
What is the next step for a patient with diarrhea, abdominal pain, and hematochezia after recent antibiotic use?
Is Zofran (ondansetron) safe to use for a pregnant patient experiencing nausea and vomiting?
What is the best method for removing a splinter, especially for patients with a history of infections or weakened immune system?
What is the diagnostic and treatment approach for a patient suspected of having chronic migraines?
Is surgical excision (cutting out) of plantar warts more effective than cryotherapy for a patient, considering potential complications and underlying medical conditions such as diabetes or impaired circulation?
What is the recommended treatment for a patient with allergic rhinitis using Clarinex (desloratadine)?
What is the priority in managing a [AGE]-year-old male with a history of cannabis and cocaine use, presenting with chest pain, syncope, hypotension, tachycardia, tachypnea, hyperthermia, and diaphoresis, considering potential life-threatening cardiac issues and drug use implications?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.